| Product Code: ETC6187005 | Publication Date: Sep 2024 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Australia`s import trend for the oral antiviral market experienced a decline, with a growth rate of -2.5% compared to the previous year. The compound annual growth rate (CAGR) from 2020 to 2024 stood at -10.3%. This negative momentum can be attributed to shifting demand patterns or changes in market dynamics affecting import volumes.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Oral Antiviral Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Oral Antiviral Market Revenues & Volume, 2022 & 2032F |
3.3 Australia Oral Antiviral Market - Industry Life Cycle |
3.4 Australia Oral Antiviral Market - Porter's Five Forces |
3.5 Australia Oral Antiviral Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.6 Australia Oral Antiviral Market Revenues & Volume Share, By Drug class, 2022 & 2032F |
3.7 Australia Oral Antiviral Market Revenues & Volume Share, By Distribution channel, 2022 & 2032F |
4 Australia Oral Antiviral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Australia |
4.2.2 Rising awareness about the benefits of oral antivirals over other forms of medication |
4.2.3 Technological advancements leading to the development of more effective oral antiviral drugs |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of oral antiviral drugs |
4.3.2 Competition from alternative treatments such as injectables or topical medications |
4.3.3 Potential side effects associated with oral antiviral drugs |
5 Australia Oral Antiviral Market Trends |
6 Australia Oral Antiviral Market, By Types |
6.1 Australia Oral Antiviral Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Australia Oral Antiviral Market Revenues & Volume, By Indication, 2022-2032F |
6.1.3 Australia Oral Antiviral Market Revenues & Volume, By Hepatitis, 2022-2032F |
6.1.4 Australia Oral Antiviral Market Revenues & Volume, By Human Immunodeficiency Virus (HIV), 2022-2032F |
6.1.5 Australia Oral Antiviral Market Revenues & Volume, By Influenza, 2022-2032F |
6.1.6 Australia Oral Antiviral Market Revenues & Volume, By Others, 2022-2032F |
6.2 Australia Oral Antiviral Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Australia Oral Antiviral Market Revenues & Volume, By Protease inhibitors, 2022-2032F |
6.2.3 Australia Oral Antiviral Market Revenues & Volume, By Reverse transcriptase inhibitors, 2022-2032F |
6.2.4 Australia Oral Antiviral Market Revenues & Volume, By Others, 2022-2032F |
6.3 Australia Oral Antiviral Market, By Distribution channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Oral Antiviral Market Revenues & Volume, By Hospital pharmacies, 2022-2032F |
6.3.3 Australia Oral Antiviral Market Revenues & Volume, By Drug store and retail pharmacies, 2022-2032F |
6.3.4 Australia Oral Antiviral Market Revenues & Volume, By Online providers, 2022-2032F |
7 Australia Oral Antiviral Market Import-Export Trade Statistics |
7.1 Australia Oral Antiviral Market Export to Major Countries |
7.2 Australia Oral Antiviral Market Imports from Major Countries |
8 Australia Oral Antiviral Market Key Performance Indicators |
8.1 Patient adherence rate to oral antiviral treatment |
8.2 Rate of new oral antiviral drug approvals by regulatory authorities |
8.3 Number of prescriptions for oral antivirals issued by healthcare providers |
9 Australia Oral Antiviral Market - Opportunity Assessment |
9.1 Australia Oral Antiviral Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.2 Australia Oral Antiviral Market Opportunity Assessment, By Drug class, 2022 & 2032F |
9.3 Australia Oral Antiviral Market Opportunity Assessment, By Distribution channel, 2022 & 2032F |
10 Australia Oral Antiviral Market - Competitive Landscape |
10.1 Australia Oral Antiviral Market Revenue Share, By Companies, 2025 |
10.2 Australia Oral Antiviral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here